Sarasota, FL -- (SBWIRE) -- 07/11/2017 -- Conjunctivitis is a communicable disease. It is also known as the pink eye in the United States and madras eye in India. Conjunctivitis is an inflammation of the conjunctiva. Conjunctivitis caused by bacteria, viruses, and allergens. It is highly contagious diseases, spread easily through direct contact of any object like towel, napkin or by coughing and sneezing. Bacterial conjunctivitis caused mainly by both gram positive bacteria and gram negative bacteria. Common bacteria responsible for conjunctivitis are Staphylococcus aureus, Pseudomonas, Serratia marcescens, Haemophilus influenza etc.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/bacterial-conjunctivitis-market

Symptoms of bacterial conjunctivitis are reddening of eyes, excess tears, thick yellow discharge, itching, burning sensation, blurred vision and increase sensitivity towards the light. Treatment includes using antibiotics both systemic and topical. Sometime Povidone-iodine 1.25% ophthalmic solution is also used in African countries like utopia, Uganda as an alternative of antibiotic due to its less cost.

Bacterial conjunctivitis market is driven by increasing incidence of conjunctivitis patients across the globe. Exact epidemiology of this disease is difficult to estimate due to its high incidence and low prevalence. Moreover, continuous increasing incidences of bacterial conjunctivitis are responsible for market growth, bacterial conjunctivitis accounts for more than 50% of the cases. Nonetheless, ongoing research and development in the healthcare sector coupled with advancement in medical technologies are expected to open growth avenues for the market over the years.

Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/bacterial-conjunctivitis-market

The report covers forecast and analysis of the bacterial conjunctivitis drug market on a regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Million). To understand the competitive landscape in the market, an analysis of Porter's Five Forces model for the bacterial conjunctivitis drug market has also been included in the study. The report also analyzes several driving and restraining factors and their impact on the market during the forecast period. The study encompasses a market attractiveness analysis, wherein product & regional segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides detailed segmentation of the bacterial conjunctivitis drug market based on product segment and regional segment. Geographically, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. Demand has been analyzed and forecasts based on the current trends for the period of six years. North America was the leading segment of bacterial conjunctivitis drug market followed by Europe in 2015. The bacterial conjunctivitis drug market is expected to witness the good growth in the Asia-Pacific region, especially in India and China in the coming years due to the rising population and pandemic nature of conjunctivitis diseases.

Key players included in the report are Allergan, Inc., Merck, Pfizer, Inc., Novartis, and others.

Browse detail report @ https://www.zionmarketresearch.com/report/bacterial-conjunctivitis-market

This report segments the global bacterial conjunctivitis markets follows:

Bacterial Conjunctivitis Market by Product Segment Analysis: (Fluoroquinolones, Macrocodes, Aminoglycosides, Others)

Bacterial Conjunctivitis Market by Regional Segment Analysis: (North America, Europe, Asia-Pacific, Latin America, The Middle East & Africa)

Inquire more before buying this report @ https://www.zionmarketresearch.com/inquiry/bacterial-conjunctivitis-market

About Zion Market Research
Zion Market Research, the market research group announced the analysis report titled 'Bacterial Conjunctivitis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2015–2021'